Cortexyme (CRTX) Appoints Marwan Sabbagh to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. FIX
9. TSCO
10. BE

Go back to Cortexyme (CRTX) Appoints Marwan Sabbagh to its Board

Cortexyme Appoints Marwan Sabbagh, MD, to its Board of Directors

March 15, 2022 8:00 AM EDT

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company pioneering upstream therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, today announced the appointment of Marwan Noel Sabbagh, MD, FAAN, a board-certified neurologist and leading expert in Alzheimers and dementia care, to the companys Board of Directors.

Dr. Sabbaghs deep expertise in neurological diseases and extensive clinical development experience makes him a valuable addition to the Cortexyme Board of Directors, said Chris Lowe, Cortexymes interim chief executive officer. Cortexyme will benefit... More